These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26547261)

  • 41. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
    Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
    J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LC-MS/MS method for the characterization of the forced degradation products of Entecavir.
    Ramesh T; Rao PN; Rao RN
    J Sep Sci; 2014 Feb; 37(4):368-75. PubMed ID: 24323372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
    Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
    J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of stress degradation products of fosinopril by using LC-MS/TOF, MS(n) and on-line H/D exchange.
    Narayanam M; Singh S
    J Pharm Biomed Anal; 2014 Apr; 92():135-43. PubMed ID: 24518132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of degradation products and process-related impurity of sutezolid by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Guo K; Zhang T; Wang Y; Jin B; Ma C
    J Pharm Biomed Anal; 2019 May; 169():196-207. PubMed ID: 30877931
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and Validation of a Stability Indicating LC-MS/MS Method for the Determination of Clenbuterol HCl.
    Prajapati KJ; Kothari C
    Drug Res (Stuttg); 2020 Dec; 70(12):552-562. PubMed ID: 32937667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LC-ESI-MS/MS evaluation of forced degradation behaviour of silodosin: In vitro anti cancer activity evaluation of silodosin and major degradation products.
    Vishnuvardhan C; Saibaba B; Allakonda L; Swain D; Gananadhamu S; Srinivas R; Satheeshkumar N
    J Pharm Biomed Anal; 2017 Feb; 134():1-10. PubMed ID: 27866053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural characterization of alkaline and oxidative stressed degradation products of lurasidone using LC/ESI/QTOF/MS/MS.
    Kumar Talluri MVN; Dharavath S; Kalariya PD; Prasanth B; Srinivas R
    J Pharm Biomed Anal; 2015 Feb; 105():1-9. PubMed ID: 25527975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolation and structural characterization of degradation products of afatinib dimaleate by LC-Q-TOF/MS/MS and NMR: cytotoxicity evaluation of afatinib and isolated degradation products.
    Chavan BB; Sawant V; Borkar RM; Ragampeta S; Talluri MVNK
    J Pharm Biomed Anal; 2019 Mar; 166():139-146. PubMed ID: 30640044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liquid chromatography/tandem mass spectrometry study of forced degradation of azilsartan medoxomil potassium.
    Swain D; Patel PN; Palaniappan I; Sahu G; Samanthula G
    Rapid Commun Mass Spectrom; 2015 Aug; 29(15):1437-47. PubMed ID: 26147484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and characterization of stress degradants of lacosamide by LC-MS and ESI-Q-TOF-MS/MS: development and validation of a stability indicating RP-HPLC method.
    Ramisetti NR; Kuntamukkala R; Lakshetti S; Sripadi P
    J Pharm Biomed Anal; 2014 Jul; 95():256-64. PubMed ID: 24699370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential degradation products of abemaciclib: Identification and structural characterization employing LC-Q/TOF-MS and NMR including mechanistic explanation.
    Kathar N; Rajput N; Jadav T; Sengupta P
    J Pharm Biomed Anal; 2024 Jan; 237():115762. PubMed ID: 37844364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of four new photodegradation products of hydroxychloroquine through LC-PDA, ESI-MSn and LC-MS-TOF studies.
    Saini B; Bansal G
    J Pharm Biomed Anal; 2013 Oct; 84():224-31. PubMed ID: 23850938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LC and LC-MS/TOF studies on stress degradation behaviour of candesartan cilexetil.
    Mehta S; Shah RP; Priyadarshi R; Singh S
    J Pharm Biomed Anal; 2010 Jul; 52(3):345-54. PubMed ID: 19505786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comprehensive forced degradation studies of Cariprazine hydrochloride using LC-HRMS/MS and in silico toxicity predictions of its degradation products.
    Jain M; Khan S
    J Pharm Biomed Anal; 2022 Sep; 219():114955. PubMed ID: 35917732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of forced degradation products of tedizolid phosphate by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Lei Y; Jin B; Ma C; Zhang T; Li T
    J Pharm Biomed Anal; 2017 May; 139():221-231. PubMed ID: 28292681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and characterization of forced degradation products of vortioxetine by LC/MS/MS and NMR.
    Ragi NC; Velma GR; Pallerla PK; Siddiqua S; Alugonda V; Rachamalla HKR; Pabbaraja S; Sripadi P
    J Pharm Biomed Anal; 2020 Sep; 188():113442. PubMed ID: 32622114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and characterization of urapidil stress degradation products by LC-Q-TOF-MS and NMR: Toxicity prediction of degradation products.
    Velip L; Dhiman V; Kushwah BS; Golla VM; Gananadhamu S
    J Pharm Biomed Anal; 2022 Mar; 211():114612. PubMed ID: 35101803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of stability-indicating method for separation and characterization of benidipine forced degradation products using LC-MS/MS.
    Kushwah BS; Thummar MM; Yadav AS; Dhiman V; Samanthula G
    Biomed Chromatogr; 2023 Jan; 37(1):e5517. PubMed ID: 36200917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective separation and characterisation of stress degradation products and process impurities of prucalopride succinate by LC-QTOF-MS/MS.
    Mahamuni BS; Jajula A; Awasthi A; Kalariya PD; Talluri MV
    J Pharm Biomed Anal; 2016 Jun; 125():219-28. PubMed ID: 27037978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.